Skip to main content
. 2021 May 20;18:24. doi: 10.1186/s12979-021-00237-w

Table 3.

Influence of age and gender on comorbidities

Age Gender
< 30 30–45 45–60 60–75 > 75 Male Female
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Hypertensiona
 No 7(5.6) 19(15.2) 41(32.8) 41(32.8) 17(13.6) 67(53.6) 58(46.4)
 Yes 0(0) 2(1.7) 17(14) 45(37.2) 57(47.1) 73(60.3) 48(39.7)
Dyslipidaemiaa
 No 7(4.9) 17(11.9) 45(31.5) 47(32.9) 27(18.9) 81(56.6) 62(43.4)
 Yes 0(0) 4(3.9) 15(14.7) 38(37.3) 45(44.1) 59(57.8) 43(42.2)
Obesity
 No 5(3) 14(8.4) 42(25.1) 56(33.5) 50(29.9) 103(61.7) 64(38.3)
 Yes 1(2.9) 2(5.9) 7(20.6) 18(52.9) 6(17.6) 17(50) 17(50)
Diabetesa
 No 7(3.9) 18(10.1) 55(30.9) 57(32) 41(23) 102(57.3) 76(42.7)
 Yes 0(0) 3(4.4) 5(7.4) 31(45.6) 29(42.6) 40(58.8) 28(41.2)
Smokera,b
 No 4(2.2) 17(9.1) 50(26.9) 65(34.9) 50(26.9) 101(54.3) 85(45.7)
 Yes 3(12) 1(4) 7(28) 6(24) 8(32) 20(80) 5(20)
 Ex 0(0) 0(0) 0(0) 8(80) 2(20) 8(80) 2(20)
Primary immunodeficiencya
 No 7(3) 21(9) 59(25.3) 83(35.6) 63(27) 133(57.1) 100(42.9)
 Yes 1(50) 0(0) 0(0) 0(0) 1(50) 1(50) 1(50)
Secundary immunodeficiency
 No 5(2.7) 16(8.6) 52(28.1) 60(32.4) 52(28.1) 98(53) 87(47)
 Yes 2(4.9) 3(7.3) 6(14.6) 21(51.2) 9(22) 28(68.3) 13(31.7)
Epidemiological background
 NHR 1(2.8) 3(8.3) 6(16.7) 8(22.2) 18(50) 18(50) 18(50)
 LIR 1(1.9) 5(9.6) 15(28.8) 16(30.8) 15(28.8) 31(59.6) 21(40.4)
 FW 1(7.1) 1(7.1) 7(50) 4(28.6) 1(7.1) 5(35.7) 9(64.3)
 CT 3(6.7) 7(15.6) 12(26.7) 23(51.1) 13(51.1) 38(65.5) 20(34.5)

All p-values either agea or genderb were < 0.001

Abbreviations: NHR Nursing home resident, LIR Live-in relative, FW Frontline worker, CT Community transmission